$34.24
-0.40 (-1.15%)
USD · as of 2026-08-21 · marketstack
Signal = open-market buys/sells (P/S); grants, exercises, tax, gifts are mechanics. Filings through 2026-06-30 only.
| Date | Insider | Role | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-20 | Naclerio Nicholas | Director | +Grant | 5,686 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Other | 5,510,516 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Conversion | 4,588,364 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Conversion | 922,152 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | −Other | 5,510,516 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Conversion | 346,020 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Conversion | 271,782 | — | — |
| 2026-04-20 | Naclerio Nicholas | Director | +Buy | 235,294 | $17.00 | $4M |
| 2026-04-20 | McAnear Justin J. | Officer | +Grant | 37,220 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Conversion | 1,224,152 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Conversion | 1,386,746 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | −Other | 1,864,065 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Other | 1,224,152 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | −Other | 1,224,152 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Grant | 76,509 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Other | 1,864,065 | — | — |
| 2026-04-20 | Luo Yuling | Director,Officer | +Conversion | 364,268 | — | — |
| 2026-04-20 | Chen Shiping | Director,Officer | +Conversion | 72,853 | — | — |
| 2026-04-20 | Chen Shiping | Director,Officer | +Conversion | 320,511 | — | — |
| 2026-04-20 | Chen Shiping | Director,Officer | −Other | 722,885 | — | — |
| 2026-04-20 | Chen Shiping | Director,Officer | +Other | 722,885 | — | — |
| 2026-04-20 | Chen Shiping | Director,Officer | +Grant | 37,220 | — | — |
| 2026-04-20 | White Timothy Ogden | Officer | +Grant | 37,220 | — | — |
| 2026-04-20 | White Timothy Ogden | Officer | −Other | 454,583 | — | — |
| 2026-04-20 | White Timothy Ogden | Officer | +Other | 454,583 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Buy | 235,294 | $17.00 | $4M |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Conversion | 271,782 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | −Other | 5,510,516 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Conversion | 922,152 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Conversion | 4,588,364 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Other | 5,510,516 | — | — |
| 2026-04-20 | Illumina Innovation Fund II GP, L.L.C. | TenPercentOwner | +Conversion | 346,020 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | −Other | 1,922,329 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | −Other | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | −Other | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | −Other | 185,163 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Conversion | 1,922,329 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Conversion | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Conversion | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Other | 185,163 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Other | 6,881,410 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Other | 1,605,645 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Other | 1,922,329 | — | — |
| 2026-04-20 | Qiming GP VIII-HC, LLC | TenPercentOwner | +Conversion | 185,163 | — | — |
SEC Form 3/4/5 through 2026-06-30 · P buy · S sell · A grant · M/X/C exercise · F tax · G gift.
A model's estimate — for research. See the Disclaimer.